🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,301 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11179467

Exenatide modifier and use thereof

BrightGene Bio-Medical Technology Co., Ltd. · Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11173164

Compositions comprising triterpenoids

REGENERA PHARMA LTD. · Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11166924

N-methyl-d-aspartate receptor allosteric modulators and methods for their use

Qingdao Primedicine Pharmaceutical Company, Ltd. · Granted Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11149036

3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine recep

MSD R&D (China) Co. Ltd. · Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11147773

Chloroquine gel and preparation method and application thereof

GUANGZHOU HYBRIBIO BIOTECH LTD. · Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11142527

Dihydropyrimidine compounds and uses thereof in medicine

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11135172

Rifabutin-based compositions and methods for treating Helicobacter pylori infection

RedHill Biopharma Ltd. · Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11135154

Medroxyprogesterone acetate injectable compositions and methods of use

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11129863

Composition, preparation method thereof, and application thereof in the prevention and tre

INFINITUS (CHINA) COMPANY LTD. · Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11104704

Peptide having cytoprotective effect against environmental pollutant and use thereof

CAREGEN CO., LTD. · Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11104689

Influenza virus replication inhibitor and use thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11103436

Peptide exhibiting wrinkle-improving activity and uses thereof

CAREGEN CO., LTD. · Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11098042

Inhibitors of influenza virus replication and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11090349

Plant extract obtained from Morus plant leaves, compositions containing same, method of ex

Botanic Century (Beijing) Co. Ltd. · Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11090272

Lurasidone solid dispersion and preparation method thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11090326

Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimin

RedHill Biopharma Ltd. · Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11090325

Compositions for treating ebola virus infection

RedHill Biopharma Ltd. · Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11083736

Compositions comprising triterpenoids

REGENERA PHARMA LTD. · Granted Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11084842

Glucopyranosyl derivative and use thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11077123

Use of bile acids and bile salts as anti bacterial agents for inhibition of bacterial conj

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11072636

Peptide for inhibiting angiogenesis and use thereof

CAREGEN CO., LTD. · Granted Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11058671

Formulations and methods of manufacturing formulations for use in colonic evacuation

RedHill Biopharma Ltd. · Granted Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11052073

Sphingosine kinase 2 inhibitor for treating coronavirus infection

RedHill Biopharma Ltd. · Granted Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11045466

Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and

Platform Brightworks Two, Ltd. · Granted Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted